ATP6AP2 and metabolic dysfunction-associated steatotic liver disease: In the current study, we used PRR antagonism, employing the 20-amino-acid peptide PRO20, to investigate the role of the PRR in modulating liver lipid metabolism in the setting of NAFLD.